MedTrace Logo

Effect of Nelutri™ on Musculoskeletal Biomarkers in Relative Sarcopenia Adults

NCT04320121 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2021-04-28

No results posted yet for this study

Summary

The investigators conduct a randomized, double-blind, placebo-controlled study to investigate the effects of Nelutri™on muscle strength, muscle mass, and muscle function in healthy adults for 12 weeks.

Conditions

  • Muscular Sarcoidosis

Interventions

DIETARY_SUPPLEMENT

Nelutri™

Nelutri™ 2,000 mg/day for 12 weeks

DIETARY_SUPPLEMENT

Placebo group

Placebo 2,000 mg/day for 12 weeks

Sponsors & Collaborators

  • Pusan National University Yangsan Hospital

    lead OTHER

Principal Investigators

  • Sang Yeoup Lee, MD · Pusan National University Yangsan Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
19 Months
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-03-11
Primary Completion
2020-12-30
Completion
2020-12-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04320121 on ClinicalTrials.gov